Peritonitis: Clinical Trials

11 trials for Peritonitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 11

Follow Peritonitis: new trials by email Literature Review of Peritonitis trials Research Report on Peritonitis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraperitoneal Hydrocortisone for Postoperative Pain and CRP Following Caesarean Section
hydrocortisone, Nornal Saline - Postoperative Pain, Caesarean Section
Phase 4CompletedRaditsya Mada Gautama, MD502026-06-252026-10-23
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis
Rheosorbilact®, Ringer lactate - Peritonitis, Intoxication
Phase 4CompletedYuria-Pharm1802018-01-102020-02-21
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)
Echinocandins - Septic Shock, Peritonitis
Phase 4CompletedCentre Hospitalier Universitaire de Nīmes242017-01-282025-12-10
IV Antibiotics With Lavage for Severe PD Peritonitis
Intravenous vancomycin & gentamicin with adjunctive lavage, Intraperitoneal vancomycin & gentamicin - Peritonitis, Kidney Failure
Phase 4CompletedAlice Ho Miu Ling Nethersole Hospital462014-03-012018-01-31
Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis
Icodextrin, glucose-based peritoneal dialysate - Peritonitis
Phase 4CompletedChinese University of Hong Kong562010-01-012016-08-10
Prospective Comparison of Primary Abdominal Closure and Vacuum Assisted Laparostomy in Treatment of Severe Peritonitis
V.A.C.- Vacuum assisted closure laparostomy (KCI) - Peritonitis
Phase 4CompletedThe Faculty Hospital Na Bulovce572008-07-012012-02-13
Use of Ointments in Prevention of Catheter Related Infections in PD
Mupirocin ointment, Polysporin Triple - End Stage Renal Disease
Phase 4CompletedUniversity Health Network, Toronto2002006-02-012015-03-18
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
tigecycline, ceftriaxone plus metronidazole - Appendicitis, Cholecystitis
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer4732005-10-012013-02-25
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
tigecycline, ceftriaxone sodium + metronidazole - Appendicitis, Cholecystitis
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer4672005-09-012013-02-25
Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD
Three 2-liter exchanges daily CAPD, Four 2-liter exchanges daily CAPD - End Stage Renal Disease, Anuria
Phase 4CompletedShanghai Jiao Tong University School of Medicine1392004-06-012016-07-22
Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
Baxter's UltraBag® and FMC Andy·Disc® - Chronic Renal Failure
Phase 4CompletedMinistry of Health, Malaysia2642002-05-012006-10-26

Narrower conditions

Kidney Failure, Chronic (4)  ·  Appendicitis (2)  ·  Cholecystitis (2)  ·  Diverticulitis (2)  ·  Abdominal Abscess (1)  ·  Abscess (1)  ·  Anuria (1)  ·  Catheter-Related Infections (1)  ·  Cross Infection (1)  ·  Intraabdominal Infections (1)  ·  Pain, Postoperative (1)  ·  Renal Insufficiency (1)  ·  Shock, Septic (1)

Broader conditions

Digestive System Diseases (11)  ·  Infections (11)  ·  Peritoneal Diseases (11)  ·  Intraabdominal Infections (10)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Disease Attributes (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Kidney Diseases (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Chronic Disease (4)  ·  Renal Insufficiency (4)

Interventions

Ceftriaxone (2)  ·  Metronidazole (2)  ·  Tigecycline (2)  ·  Caspofungin (1)  ·  Echinocandins (1)  ·  Gentamicins (1)  ·  Hydrocortisone (1)  ·  Icodextrin (1)  ·  Micafungin (1)  ·  Negative-Pressure Wound Therapy (1)  ·  Ringer's Lactate (1)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (2)  ·  Alice Ho Miu Ling Nethersole Hospital (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Chinese University of Hong Kong (1)  ·  Ministry of Health, Malaysia (1)  ·  Raditsya Mada Gautama, MD (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  The Faculty Hospital Na Bulovce (1)  ·  University Health Network, Toronto (1)  ·  Yuria-Pharm (1)

Countries

Hong Kong (3)  ·  Australia (2)  ·  Canada (2)  ·  China (2)  ·  France (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Chile (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Georgia (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)

Top investigators

Claire Roger, MD (1)  ·  Ondrej Ryska, MD (1)  ·  Raditsya M Gautama, MD (1)  ·  Siu-Man Wong, MBChB, FRCPC (1)  ·  Vanita Jassal, MD (1)  ·  Wei Fang, MD, PhD (1)  ·  Zaki Morad, MRCP, FRCP (1)

Results publications

PMID 18178950, PMID 20670293, PMID 22134627, PMID 22439781, PMID 24578470, PMID 33846133

NIH funding

2016 (1)